Yuko Izuhara

1.7k total citations
33 papers, 1.4k citations indexed

About

Yuko Izuhara is a scholar working on Clinical Biochemistry, Nephrology and Cancer Research. According to data from OpenAlex, Yuko Izuhara has authored 33 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Clinical Biochemistry, 13 papers in Nephrology and 9 papers in Cancer Research. Recurrent topics in Yuko Izuhara's work include Advanced Glycation End Products research (19 papers), Chronic Kidney Disease and Diabetes (8 papers) and Protease and Inhibitor Mechanisms (8 papers). Yuko Izuhara is often cited by papers focused on Advanced Glycation End Products research (19 papers), Chronic Kidney Disease and Diabetes (8 papers) and Protease and Inhibitor Mechanisms (8 papers). Yuko Izuhara collaborates with scholars based in Japan, Belgium and India. Yuko Izuhara's co-authors include Toshio Miyata, Kiyoshi Kurokawa, Charles van Ypersele de Strihou, Reiko Inagi, Masaomi Nangaku, Shunya Takizawa, Akira Saitō, Kôji Uchida, Katsunori Horie and Yasuhiko Ueda and has published in prestigious journals such as Journal of Clinical Investigation, Brain Research and Biochemical and Biophysical Research Communications.

In The Last Decade

Yuko Izuhara

33 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuko Izuhara Japan 19 495 468 310 259 240 33 1.4k
Mitsunori Yagame Japan 18 613 1.2× 338 0.7× 253 0.8× 249 1.0× 90 0.4× 72 1.2k
Bieke F. Schrijvers Denmark 15 651 1.3× 308 0.7× 499 1.6× 306 1.2× 83 0.3× 18 1.5k
Markus Lassila Finland 21 309 0.6× 358 0.8× 490 1.6× 412 1.6× 52 0.2× 34 1.5k
Elyce Ozols Australia 13 744 1.5× 392 0.8× 534 1.7× 256 1.0× 97 0.4× 23 1.7k
Kenneth Cartwright United States 11 139 0.3× 546 1.2× 355 1.1× 395 1.5× 123 0.5× 13 1.5k
Steven Harwood United Kingdom 16 386 0.8× 128 0.3× 472 1.5× 133 0.5× 81 0.3× 25 1.5k
Stacey Ruiz United States 8 463 0.9× 180 0.4× 937 3.0× 215 0.8× 68 0.3× 12 1.7k
Tomoko Namba‐Hamano Japan 17 526 1.1× 202 0.4× 502 1.6× 125 0.5× 94 0.4× 57 1.7k
Guixia Ding China 25 633 1.3× 151 0.3× 937 3.0× 202 0.8× 192 0.8× 68 2.0k
Daisuke Ogawa Japan 22 605 1.2× 259 0.6× 793 2.6× 816 3.2× 212 0.9× 51 2.2k

Countries citing papers authored by Yuko Izuhara

Since Specialization
Citations

This map shows the geographic impact of Yuko Izuhara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuko Izuhara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuko Izuhara more than expected).

Fields of papers citing papers by Yuko Izuhara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuko Izuhara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuko Izuhara. The network helps show where Yuko Izuhara may publish in the future.

Co-authorship network of co-authors of Yuko Izuhara

This figure shows the co-authorship network connecting the top 25 collaborators of Yuko Izuhara. A scholar is included among the top collaborators of Yuko Izuhara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuko Izuhara. Yuko Izuhara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kodama, Hidehiko, et al.. (2011). Structure-Activity Relationships of New N-Acylanthranilic Acid Derivatives as Plasminogen Activator Inhibitor-1 Inhibitors. Chemical and Pharmaceutical Bulletin. 59(2). 215–224. 8 indexed citations
2.
Izuhara, Yuko, et al.. (2010). Structure-Activity Relationships of New 2-Acylamino-3-thiophenecarboxylic Acid Dimers as Plasminogen Activator Inhibitor-1 Inhibitors. Chemical and Pharmaceutical Bulletin. 58(5). 615–619. 16 indexed citations
3.
Tominaga, Naoto, Annie Robert, Yuko Izuhara, et al.. (2009). Very high doses of valsartan provide renoprotection independently of blood pressure in a type 2 diabetic nephropathy rat model. Nephrology. 14(6). 581–587. 11 indexed citations
4.
Miyata, Toshio & Yuko Izuhara. (2008). Inhibition of Advanced Glycation End Products. Annals of the New York Academy of Sciences. 1126(1). 141–146. 12 indexed citations
5.
Ohtomo, Shuichi, Masaomi Nangaku, Yuko Izuhara, et al.. (2008). The role of megsin, a serine protease inhibitor, in diabetic mesangial matrix accumulation. Kidney International. 74(6). 768–774. 13 indexed citations
6.
7.
Izuhara, Yuko, Toshio Sada, Hiroaki Yanagisawa, et al.. (2008). A Novel Sartan Derivative With Very Low Angiotensin II Type 1 Receptor Affinity Protects the Kidney in Type 2 Diabetic Rats. Arteriosclerosis Thrombosis and Vascular Biology. 28(10). 1767–1773. 16 indexed citations
8.
Takizawa, Shunya, Yuko Izuhara, Yasuko Kitao, et al.. (2007). A novel inhibitor of advanced glycation and endoplasmic reticulum stress reduces infarct volume in rat focal cerebral ischemia. Brain Research. 1183. 124–137. 26 indexed citations
9.
Inagi, Reiko, Masaomi Nangaku, Nobuteru Usuda, et al.. (2005). Novel Serpinopathy in Rat Kidney and Pancreas Induced by Overexpression of Megsin. Journal of the American Society of Nephrology. 16(5). 1339–1349. 24 indexed citations
10.
Miyata, Toshio, Makoto Yamamoto, & Yuko Izuhara. (2005). From Molecular Footprints of Disease to New Therapeutic Interventions in Diabetic Nephropathy. Annals of the New York Academy of Sciences. 1043(1). 740–749. 10 indexed citations
11.
Izuhara, Yuko, Masaomi Nangaku, Reiko Inagi, et al.. (2005). Renoprotective Properties of Angiotensin Receptor Blockers beyond Blood Pressure Lowering. Journal of the American Society of Nephrology. 16(12). 3631–3641. 157 indexed citations
12.
Ishikawa, Naoyoshi, Toshio Miyata, Yasuhiko Ueda, et al.. (2003). Affinity adsorption of glucose degradation products improves the biocompatibility of conventional peritoneal dialysis fluid. Kidney International. 63(1). 331–339. 17 indexed citations
13.
Miyata, Toshio, Reiko Inagi, Masaomi Nangaku, et al.. (2002). Overexpression of the serpin megsin induces progressive mesangial cell proliferation and expansion. Journal of Clinical Investigation. 109(5). 585–593. 36 indexed citations
14.
Miyata, Toshio, Reiko Inagi, Masaomi Nangaku, et al.. (2002). Overexpression of the serpin megsin induces progressive mesangial cell proliferation and expansion. Journal of Clinical Investigation. 109(5). 585–593. 3 indexed citations
15.
Miyata, Toshio, Reiko Inagi, Masaomi Nangaku, et al.. (2002). Overexpression of the serpin megsin induces progressive mesangial cell proliferation and expansion. Journal of Clinical Investigation. 109(5). 585–593. 46 indexed citations
16.
Miyata, T, Katsunori Horie, Yuji Fujita, et al.. (2000). Advanced glycation and lipidoxidation of the peritoneal membrane: Respective roles of serum and peritoneal fluid reactive carbonyl compounds. Kidney International. 58(1). 425–435. 106 indexed citations
17.
Ueda, Yasuhiko, Toshio Miyata, Éric Goffin, et al.. (2000). Effect of dwell time on carbonyl stress using icodextrin and amino acid peritoneal dialysis fluids. Kidney International. 58(6). 2518–2524. 65 indexed citations
18.
Miyata, Toshio, Yasuhiko Ueda, Koichi Asahi, et al.. (2000). Mechanism of the Inhibitory Effect of OPB-9195 [(±)-2-Isopropylidenehydrazono-4-oxo-thiazolidin-5-ylacetanilide] on Advanced Glycation End Product and Advanced Lipoxidation End Product Formation. Journal of the American Society of Nephrology. 11(9). 1719–1725. 83 indexed citations
19.
Asahi, Koichi, Kohji Ichimori, Hiroe Nakazawa, et al.. (2000). Nitric oxide inhibits the formation of advanced glycation end products. Kidney International. 58(4). 1780–1787. 36 indexed citations
20.
Ueda, Yasuhiko, et al.. (1998). Implication of Altered Redox Regulation by Antioxidant Enzymes in the Increased Plasma Pentosidine, an Advanced Glycation End Product, in Uremia. Biochemical and Biophysical Research Communications. 245(3). 785–790. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mitsunori Yagame Breakdown of academic impact, for papers by Bieke F. Schrijvers Breakdown of academic impact, for papers by Markus Lassila Breakdown of academic impact, for papers by Elyce Ozols Breakdown of academic impact, for papers by Kenneth Cartwright Breakdown of academic impact, for papers by Steven Harwood Breakdown of academic impact, for papers by Stacey Ruiz Breakdown of academic impact, for papers by Tomoko Namba‐Hamano Breakdown of academic impact, for papers by Guixia Ding Breakdown of academic impact, for papers by Daisuke Ogawa
Rankless by CCL
2026